pSivida Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Announces NDA for Medidur Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs. Top-Line Data from First Trial Expected 12/2015